References
1. Peerless SA, Noiman AH. Etiology of otitis media with effusion:
antihistamines–decongestants. Laryngoscope 1980; 90:1852-1864.
2. Alberty J, Stoll W. The effect of antiallergic intranasal
formulations on ciliary beat frequency of human nasal epithelium in
vitro. Allergy 1998; 53:986-989.
3. Joki S, Toskala E, Saano V, Nuutinen J. Correlation between ciliary
beat frequency and the structure of ciliated epithelia in pathologic
human nasal mucosa. Laryngoscope 1998; 108:426-430.
4. Li D, Shirakami G, Zhan X, Johns RA. Regulation of ciliary beat
frequency by the nitric oxide-cyclic guanosine monophosphate signaling
pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol 2000;
23:175-181.
5. Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W, Snidvongs
K. Antihistamines for treating rhinosinusitis: systematic review and
meta-analysis of randomised controlled studies. J Laryngol Otol 2018;
132:105-110.
6. Braverman I, Wright ED, Wang CG, Eidelman D, Frenkiel S. Human nasal
ciliary-beat frequency in normal and chronic sinusitis subjects. J
Otolaryngol 1998; 27:145-152.
7. Wang DY, Wardani RS, Singh K et al. A survey on the management of
acute rhinosinusitis among Asian physicians. Rhinology 2011; 49:264-271.
8. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin
Immunol 2010; 125:S103-115.
9. Kirtsreesakul V, Blair C, Yu X, Thompson K, Naclerio RM.
Desloratadine partially inhibits the augmented bacterial responses in
the sinuses of allergic and infected mice. Clin Exp Allergy 2004;
34:1649-1654.
10. Austin PC. A critical appraisal of propensity-score matching in the
medical literature between 1996 and 2003. Stat Med 2008; 27:2037-2049.
11. Dinse GE, Lagakos SW. Nonparametric estimation of lifetime and
disease onset distributions from incomplete observations. Biometrics
1982; 38:921-932.
12. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part
II: multivariate data analysis–an introduction to concepts and
methods. Br J Cancer 2003; 89:431-436.
13. Chen CF, Wu KG, Hsu MC, Tang RB. Prevalence and relationship between
allergic diseases and infectious diseases. J Microbiol Immunol Infect
2001; 34:57-62.
14. Holzmann D, Willi U, Nadal D. Allergic rhinitis as a risk factor for
orbital complication of acute rhinosinusitis in children. Am J Rhinol
2001; 15:387-390.
15. Novak I, Falus A. Molecular biology and role of histamine in
physiological and pathological reactions. A review. Acta Biol Hung 1997;
48:385-394.
16. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by
histamine of IL-4 and interferon-gamma (IFN-gamma) release according to
the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997;
108:545-551.
17. Jeannin P, Delneste Y, Gosset P et al. Histamine induces
interleukin-8 secretion by endothelial cells. Blood 1994; 84:2229-2233.
18. Miki I, Kusano A, Ohta S et al. Histamine enhanced the
TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular
endothelial cells. Cell Immunol 1996; 171:285-288.
19. Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop G, World
Health Organization. Allergic rhinitis and its impact on asthma. J
Allergy Clin Immunol 2001; 108:S147-334.
20. Antunes MB, Cohen NA. Mucociliary clearance – a critical upper
airway host defense mechanism and methods of assessment. Curr Opin
Allergy Clin Immunol 2007; 7:5-10.
21. Eliezer N, Sade J, Silberberg A, Nevo AC. The role of mucus in
transport by cilia. Am Rev Respir Dis 1970; 102:48-52.
22. Sleigh MA, Blake JR, Liron N. The propulsion of mucus by cilia. Am
Rev Respir Dis 1988; 137:726-741.
23. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation
of mucociliary clearance in health and disease. Eur Respir J 1999;
13:1177-1188.
Figure legends
Figure 1. Survival curves of Patients in AH and non-AH group (AH;
antihistamine, non-AH; non-antihistamine)
Figure 2. In the subgroup analysis of the AH group, there was no
significant difference between the four subgroup. (“1 week” if the
consecutive duration of antihistamine usage is less than 1 week, “2
week” if the duration is less than 2 week, “1 month” if the duration
is less than 4 week, and “over 1 month” if the duration is equal or
more than 4 week) (p=0.70)
Table 1. Characteristics of the study population